The overexpression of PLK1 is linked to the formation, metastasis, prognosis and overall survival rate of various tumor types, including breast cancer, non-small cell lung cancer, prostate cancer, and non-Hodgkin lymphoma. Here, PLK1 is linked to non-small cell lung carcinoma.